GSK to Acquire Nuvalent for $10.6 Billion in All-Cash Tender Offer
NUVL sits 73% above its 52-week low of $71.13 on elevated volume (1.8× avg).
Summary
GSK is acquiring Nuvalent for $10.6 billion in an all-cash tender offer, offering a significant premium to shareholders and gaining access to Nuvalent's advanced oncology drug pipeline.
Key Events · M&A and Partnerships · NUVL
-
Acquisition Agreement
GSK plc has entered into a definitive merger agreement to acquire Nuvalent, Inc. for an aggregate equity value of $10.6 billion through an all-cash tender offer.
-
Significant Premium Offered
Shareholders will receive $124 per share in cash, representing a 40% premium to Nuvalent's last closing price and a 26% premium to the 30-calendar day Volume-Weighted Average Price (VWAP). The offer price is also significantly above the company's 52-week high of $113.015.
-
Strategic Oncology Pipeline Acquired
GSK gains Nuvalent's oncology pipeline, including two late-stage, potential best-in-class NSCLC inhibitors, zidesamtinib (ROS1) and neladalkib (ALK), both with FDA Breakthrough Therapy and Orphan Drug Designations and target decision dates in 2026. The acquisition also includes a Phase I HER2 inhibitor and preclinical programs.
-
Financial Impact for Acquirer
The acquisition is expected to be accretive to GSK's sales and core operating profit from 2027 and core EPS from 2029, accelerating its entry into lung cancer.
Analysis · NUVL · Life Sciences
GSK has initiated a tender offer to acquire Nuvalent for $124 per share in cash, valuing the company at $10.6 billion. This represents a substantial 40% premium to Nuvalent's last closing price and is significantly above its 52-week high, securing its promising oncology pipeline, including two late-stage NSCLC inhibitors with FDA Priority Review.
At the time of this filing, NUVL was trading at $122.85 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7B. The 52-week trading range was $71.13 to $113.02. This filing was assessed with positive market sentiment and an importance score of 10 out of 10.